# Cc Cover Letter

> Use when drafting the cover letter (and optional presubmission inquiry) for a Cancer Cell (Cell Press) submission — framing significance, fit, novelty, and suggested/excluded reviewers. It writes the letter; it does not edit the manuscript itself.

- Skill: `thedixitjain/cc-cover-letter` (Agent Skill)
- Install (CLI): `npx skillmds add thedixitjain/cc-cover-letter`
- Raw SKILL.md: https://api.skillmd.com/api/skills/thedixitjain/cc-cover-letter/raw
- Safety review: pending
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: thedixitjain (https://skillmd.com/u/thedixitjain)
- Updated: 2026-09-09
- Page: https://skillmd.com/skills/thedixitjain/cc-cover-letter

---



# Cover Letter & Presubmission Inquiry (cc-cover-letter)

## When to trigger

- Preparing the cover letter for full submission
- Considering a Cell Press **presubmission inquiry** to gauge fit
- Need to suggest or exclude reviewers
- Need to state exclusivity / prior-communication / preprint status

## Presubmission inquiry (optional, fit-saving)

Cell Press allows a short editorial inquiry before full submission. Use it to test fit when uncertain:

- 1 short paragraph: the central finding and why it suits Cancer Cell.
- Attach the abstract/Summary and a key figure or graphical abstract.
- Ask directly whether the editors would welcome a full submission.

## Cover-letter structure (full submission)

1. **Opening** — addressed to the editor; manuscript title and that it is submitted to Cancer Cell.
2. **The advance in 2–3 sentences** — the mechanism and the translational relevance, in plain language a broad cancer audience grasps.
3. **Why Cancer Cell** — fit with the journal's mechanism + translational scope and interest to its readership.
4. **Evidence strength** — note the orthogonal validation (cells + in vivo + human/patient data) that supports the claim.
5. **Novelty vs. closest prior work** — one sentence on what is new and why now.
6. **Declarations** — original, not under consideration elsewhere; preprint status; any prior editorial communication or transfer; related manuscripts in press.
7. **Reviewer suggestions / exclusions** — see below.
8. **Close** — corresponding author and contact.

## Reviewers

- **Suggest** several genuine experts (different institutions; no recent collaborators, co-authors, mentors/mentees, or same-institution colleagues — avoid conflicts).
- **Exclude** direct competitors only with a brief, professional reason.
- Keep suggestions current and reachable; do not pad with marginal names.

## Calibrate the pitch

- Match claims to evidence exactly as in the manuscript (no extra promises in the letter).
- Lead with the discovery; do not bury it under background.
- Keep it to roughly one page; respectful, specific, not promotional fluff.

## Checklist

- [ ] Title and target journal stated up front
- [ ] Advance summarized in 2–3 plain sentences (mechanism + translational point)
- [ ] Explicit "why Cancer Cell" fit paragraph
- [ ] Orthogonal validation noted as evidence strength
- [ ] Novelty vs. closest prior work stated
- [ ] Originality / preprint / prior-communication declarations included
- [ ] Suggested reviewers (conflict-free) and any exclusions with reasons
- [ ] Corresponding author + contact; ~1 page; claims match the paper

## Anti-patterns

- Overstating impact beyond what the manuscript shows
- A generic letter that never says why Cancer Cell specifically
- Suggesting close collaborators or same-institution reviewers
- Excluding many competitors without justification (reads defensively)
- Omitting preprint or prior-communication disclosure
- A multi-page essay restating the abstract


## Cover-letter pass for Cancer Cell

Use this as a second-pass capability check. First lock the cancer context, mechanism, model system, validation chain, and translational boundary; then test whether the manuscript addresses cancer-biology reviewers who expect mechanistic oncology, translational relevance, and strong multi-modal validation.

- **Primary move:** Make the letter a routing document: contribution, fit, compliance, conflicts, and the single reason the editor should send the paper to review.
- **Decision ledger:** return `claim / evidence / blocker / next edit` rows so the next pass can patch the manuscript directly.
- **Neighbor test:** compare against Cell for broader biology, Nature Cancer for oncology breadth, Clinical Cancer Research for clinical translation; if the neighboring outlet has the stronger audience claim, recommend re-routing before polishing.
- **Verification floor:** before submission-ready advice, re-open `resources/official-source-map.md` for volatile rules and name the one unresolved fact that could change the recommendation.

## Output format

```
【Inquiry or full submission】which
【Advance (2–3 sentences)】...
【Why Cancer Cell】...
【Evidence strength line】orthogonal validation: ...
【Declarations】originality / preprint / prior comms
【Reviewers】suggested (conflict-free): [...]; excluded: [...]
【Length / tone】~1 page, claims match paper? Y/N
【Next step】cc-submission
```

---

**Source:** [`brycewang-stanford/Awesome-Journal-Skills`](https://github.com/brycewang-stanford/Awesome-Journal-Skills) → `Cancer-Cell-Skills/skills/cc-cover-letter/SKILL.md`